As few physiological roles for TEM8 have been confirmed and TEM8 is mainly expressed by cancer cells and cancer-associated vasculature [4, 37], TEM8 could be a promising target for blocking tumor angiogenesis without eliciting the same side-effects and toxicity as other anti-angiogenic cancer therapies [38–40]. The gene discussed is ANTXR1; the disease is neoplasm.